AI technologies being developed today will lead to new capabilities tomorrow and enable new business applications the day after.
Resources
28 September 2020
17 September 2020
Data Integrity: Technical Controls That Demonstrate Trust. Achieve compliance and maintain data integrity with the latest Thermo Scientific™ Chromeleon™ 7.3 Chromatography Data System (CDS),which provides all the necessary preventative and technical controls, built into one
15 September 2020
Now, more than ever, there is a growing need for integration and optimization in the laboratory.
11 September 2020
Looking to get started with AI but not sure where to begin? Read NVIDIA's quick start guide and learn how to set your next AI project up for success.
10 September 2020
Carlo Ruiz, EMEA director of AI Data Center Solutions at Nvidia gives his thoughts on the rising popularity of Conversational AI
Pages
Latest issue
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
